OWC Pharmaceutical Research Corp (OWCP)

[Hercules1]

OWCP:

read the bolded part again. it spells out something that was missed. this is beyond huge: she will oversee the "commercialization".

*********now what does that tell you? it tells you that our cream works. that is how much OWCP has advanced with this cream. they are actually planning for "commercialization".



OWC Pharmaceutical Research Corp. (OTCQB: OWCP), ("OWC" or the "Company"), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced the appointment of Dr. Sharon Rozenblat as Senior Advisor to the Scientific Advisory Board of its wholly-owned Israeli subsidiary, One World Cannabis Ltd ("OWC Israel").


Dr. Rozenblat will be tasked with overseeing the completion of the pre-clinical safety studies on the Company's treatment for psoriasis, which commenced in November 2016.


Dr. Rozenblat will also steer the Company's efforts to commercialize OWC's cannabis-based formulations and delivery mechanisms.






Dr. Yehuda Baruch, OWC's Chief Scientific Officer, commented on the appointment, "Dr. Rozenblat has had a significant impact in the field of dermatology, specifically with regard to botanical formulations. With more than 15 years' experience in the research and development of herbal extracts and related products, as well as considerable experience in the design and management of clinical trials, she is the perfect complement to our scientific team."